The sampling is accomplished by using the Bayesian method discussed above to infer posterior existence probabilities for each edge.
The Ar/O2 plasma oxidation processing of the samples was accomplished using a homemade plasma-enhanced CVD (PECVD) apparatus.
The analysis of the samples was accomplished by solid phase extraction (SPE) followed by liquid chromatography mass spectrometry (LC MS).
The detection of the AAS in the samples was accomplished by searching (i) the mass spectrometric (MS) spectra against the library developed to identify possible positives and (ii) by comparison of the tandem mass spectrometric (MS/MS) spectra produced after fragmentation of the possible positives with a complete set of spectra that have previously been assigned to the software.
Dispersion of the sample was accomplished by rotating end-over-end for 2 3 h followed by sonication for 3 5 min. The suspension was then filtered through a mesh screen, with the collected solid material rinsed with 10 mL PBS.
Fine MWCNT dispersion during melt compounding of the samples is accomplished by means of a novel non-specific, non-covalent functionalization method.
Tissue sampling was accomplished at the time of surgical intervention.
Sampling was accomplished using a Conductivity, Temperature and Depth (CTD) probe Sea-Bird Electronicss, Bellevue, WA) and a rosette equipped with 10-liter Niskin bottles fitted with silicone closure springs.
Human papillomavirus genotyping of these samples was accomplished by pyrosequencing (Biotage, Foxboro, MA, USA) performed according to the manufacturer's instructions.
To study removal time, sampling was accomplished each 30 min while sample was exposed to light.
Sampling was accomplished at regular intervals (5, 10, 25, 50 and 95 min), and the extracts obtained were filtered through paper filter and stored at −20 °C until analysed.
